Main
Portfolio Index > 2005 Genetic
Index > MOLECULAR PHARMA
NIDA Genetics Molecular Pharma Portfolio Listing A - Z
| |
|
 |

|
| |
|
 |
| BACKES, ERIC N |
Cocaine
and Gene Expression in VTA Dopamine Neurons |
| |
5F31DA017431-02 |
| |
|
| BARI, AUSAF A |
Role
of TrkB and TrkC in Cocaine-Induced Sensitization |
| |
5F30DA014205-05 |
| |
|
| BARR, GORDON A |
Opiate
Withdrawal & Tolerance: Development & Plasticity |
| |
5R01DA006600-14 |
| |
|
| BARRES, BEN A |
Role
of Glia in the Formation of Functional Synapses |
| |
5R01DA015043-05 |
| |
|
| BAYER, BARBARA M |
Neurobiology
of Drug Abuse |
| |
2T32DA007291-11A1 |
| |
|
| BELOUSOV, ANDREI B |
CHOLINERGIC
REGULATION IN THE HYPOTHALAMUS |
| |
5R01DA015088-02 |
| |
|
| BENAVIDES, DAVID R |
MINORITY
PREDOCTORAL FELLOWSHIP PROGRAM |
| |
1F31DA020199-01 |
| |
|
| BLAKELY, RANDY D |
Regulation
of Serotonin Transporters |
| |
2R01DA007390-15 |
| |
|
| BLONDELLE, SYLVIE E |
Immunogenic
epitopes of rare HIV mutants as vaccines |
| |
1R43DA021175-01 |
| |
|
| BRUCHAS, MICHAEL R |
Kappa-opioid
mediated stress response |
| |
1F32DA020430-01 |

|
| |
|
 |

|
| |
|
 |

|
| |
|
 |

|
| |
|
 |

|
| |
|
 |

|
| |
|
 |
| HEMBY, SCOTT E |
Accumbens-pallidal
GABA and morphine reinforcement |
| |
5R01DA013234-05 |
| |
|
| HINES, CHRISTINA S |
SUBSTRATE
AND INHIBITOR SPECIFICITY IN NEUROPEPTIDASES |
| |
5F30DA014596-05 |
| |
|
| HOLMES, KING K |
Antiretroviral
Adherence & Positive Prevention for High-Risk Women in
Kenya |
| |
3P30AI027757-18S1 |
| |
|
| HOLMES, KING K |
DC-SIGN/R
Polymorphisms and HIV-1 Infection in China |
| |
3P30AI027757-18S3 |
| |
|
| HOLTZMAN, STEPHEN G |
Maternal
Separation: Rat Model of Opioid Vulnerability |
| |
5R01DA014122-04 |
| |
|
| HOOK, VIVIAN Y |
Biosynthesis
of Enkephalin Opioid Peptides |
| |
5R01DA004271-20 |
| |
|
| HOXIE, JAMES A |
Center
For AIDS Research |
| |
5P30AI045008-07 |
| |
|
| HRUBY, VICTOR J |
NOVEL
NON-PEPTIDE OPIOID LIGANDS FOR PAIN |
| |
2R01DA013449-06 |
| |
|
| HRUBY, VICTOR J |
New
Modalities for Treatment of Pain and Drug Abuse |
| |
3P01DA006284-15S1 |
| |
|
| HRUBY, VICTOR J |
New
Modalities for Treatment of Pain and Drug Abuse |
| |
5P01DA006284-15 |
| |
|
| HURD, YASMIN L |
Dynorphin
/kappa mesolimbic system in heroin abuse |
| |
5R01DA015446-03 |

|
| |
|
 |

|
| |
|
 |

|
| |
|
 |

|
| |
|
 |
| LANDAU, EMMANUEL M |
Translational
control of LTP |
| |
5R01DA015863-03 |
| |
|
| LANDRY, CHARLES F |
Nicotine
and Gene Expression in Adolescent Brain |
| |
5R01DA019153-02 |
| |
|
| LAW, PING-YEE |
G
PROTEINS AND OPIOID RECEPTOR FUNCTIONS |
| |
5K05DA000513-05 |
| |
|
| LAW, PING-YEE |
G
PROTEINS AND OPIOID RECEPTOR FUNCTIONS |
| |
5R01DA007339-15 |
| |
|
| LESTER, ROBIN A |
Subunit-specific
Regulation/Neuronal Nicotinic Receptors |
| |
5R01DA011940-06 |
| |
|
| LEVITT, PAT R |
Brain
Structure & Function after Fetal Cocaine Exposure |
| |
5R01DA011165-11 |
| |
|
| LI, MING D |
Deciphering
genes and pathways in nicotine dependence |
| |
5R01DA013783-06 |
| |
|
| LI, MING D |
Deciphering
genes and pathways in nicotine dependence |
| |
7R01DA013783-07 |
| |
|
| LIANG, YIQING |
High
throughout phenotypic screen: drug effects on home |
| |
3R44DA014889-03S1 |
| |
|
| LICHTMAN, ARON H |
Endocannabinoid
modulation of memory |
| |
5R01DA015683-02 |
| |
|
| LINDBERG, IRIS |
Opioid
Peptide Synthesizing Enzymes |
| |
5R01DA005084-18 |
| |
|
| LOH, HORACE H |
Center
on Molecular and Cell Biology of Drug Abuse |
| |
5P50DA011806-08 |
| |
|
| LOH, HORACE H |
NEUROCHEMICAL
BASIS OF NARCOTIC ADDICTION |
| |
5R01DA000564-33 |
| |
|
| LUKAS, RONALD J |
Molecular
Bases for Effects of Nicotine |
| |
5R01DA015389-03 |

|
| |
|
 |
| MADRAS, BERTHA K |
Cocaine-Molecular
Targets/Brain Imaging and Medications |
| |
5K05DA015305-04 |
| |
|
| MADRAS, BERTHA K |
Evaluation
of Novel Cocaine Medications |
| |
5R01DA011558-09 |
| |
|
| MAHATA, SUSHIL K |
Chromaffin
Cell physiology: Novel molecular approaches |
| |
2R01DA011311-06A2 |
| |
|
| MANTSCH, JOHN R |
Stress
response and HPA regulation in cocaine addiction |
| |
5R01DA015758-04 |
| |
|
| MARKS, MICHAEL J |
ALPHA
CONOTOXIN MII--SELECTIVE NICOTINIC RECEPTOR PROBE |
| |
5R01DA012242-07 |
| |
|
| MARTIN, BILLY R |
CENTER
FOR DRUG ABUSE RESEARCH |
| |
5P50DA005274-18 |
| |
|
| MATSUMOTO, RAE R |
Cocaine,
Sigma Receptors and Fra-2 |
| |
1R21DA017756-01A1 |
| |
|
| MELIKIAN, HALEY E |
Trafficking
and Regulation of Monoamine Transporters |
| |
5R01DA015169-04 |
| |
|
| MERMELSTEIN, PAUL G |
NFAT-mediated
gene expression and striatal plasticity |
| |
1R01DA017881-01A2 |

|
| |
|
 |

|
| |
|
 |

|
| |
|
 |

|
| |
|
| |

|
| |
|
 |

|
| |
|
 |
| SANDERS-BUSH, ELAINE |
Hallucinogens
and Serotonin Signal Transduction |
| |
5R01DA005181-16 |
| |
|
| SCHILTZ, CRAIG A |
Molecular
Basis of Addiction: Conditioning and Relapse |
| |
5F30DA016503-03 |
| |
|
| SCHMIDT, HEATH D |
Eph
Receptors and Behavioral Sensitization to Cocaine |
| |
5F31DA016824-03 |
| |
|
| SHARP, BURT M |
Interaction
Between Nicotine and Stress |
| |
2R01DA003977-21A2 |
| |
|
| SIGGINS, GEORGE R |
Morphine
Like Brain Peptides-Cellular Neurobiology |
| |
5R01DA003665-22 |
| |
|
| SMITH, DESMOND J |
Voxelation:
a new method for 3D gene expression analysis |
| |
5R01DA015802-04 |
| |
|
| SMITH, JAMES E |
Neurobiological
Parameters of Cocaine Reinforcement |
| |
5R01DA003628-18 |
| |
|
| STOWERS, RONALD S |
Genetic
Dissection of Synaptic Transmission |
| |
1K01DA019458-01 |
| |
|
| SULZER, DAVID L |
Presynaptic
mechanisms in dopamine neurotransmission |
| |
5R01DA007418-12 |
| |
|
| SUMIKAWA, KATUMI |
Long-term
Potentiation and Nicotine Withdrawal |
| |
5R01DA014542-04 |

|
| |
|
 |
|
| |
|
| |
|
 |
No Names at this time.

|
| |
|
 |

|
| |
|
 |
| |